Dopamine-Rotex IV Injection

Introduction

Dopamine-Rotex IV Injection 200 mg/5 ml is a medication used primarily in the management of certain types of shock, such as cardiogenic shock, and to support blood pressure and kidney function in critically ill patients. It is a synthetic form of dopamine, a naturally occurring neurotransmitter that plays a crucial role in various physiological functions.

Uses

Dopamine-Rotex IV Injection 200 mg/5 ml is used in clinical settings for:

Management of shock, particularly cardiogenic and septic shock.
Support of blood pressure and cardiac output in critically ill patients.
Improving renal perfusion in patients with acute renal failure.

Brand Name	Dopamine-Rotex
Type	IV Injection
Weight	200 mg/5 ml
Generic	Dopamine Hydrochloride
Manufacturer	City Overseas Ltd. (Mfg. by: Rotexmedica GmbH, Germany)
Available in	English বাংলা

Mechanism of Action

Dopamine-Rotex IV Injection 200 mg/5 ml acts on various receptors in the body:

Dopaminergic Receptors: Stimulates D1 and D2 receptors to enhance renal blood flow and promote diuresis.
Beta-Adrenergic Receptors: Increases heart rate and myocardial contractility, improving cardiac output.
Alpha-Adrenergic Receptors: At higher doses, it can cause vasoconstriction, which raises blood pressure.

How Long Does It Take to Work?

The onset of action of Dopamine-Rotex IV Injection 200 mg/5 ml is typically within minutes after administration. The effects on blood pressure and renal perfusion can be observed shortly after infusion begins. The duration of action is relatively short, requiring continuous infusion to maintain therapeutic effects.

Absorption

Dopamine-Rotex IV Injection 200 mg/5 ml is administered intravenously, allowing for immediate and complete absorption into the bloodstream. It is not given orally due to poor absorption and rapid metabolism in the gastrointestinal tract.

Route of Elimination

Dopamine is metabolized in the liver and other tissues. It is primarily broken down by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) into inactive metabolites. The metabolites are then excreted in the urine.

Dosage

Adult dose: Where appropriate, the circulating blood volume must be restored with a suitable plasma expander or whole blood, prior to administration of dopamine. Begin infusion of dopamine hydrochloride solution at dosage of 2 to 5 micrograms/kg/min in patients who are likely to respond to a modest increment of heart force and renal perfusion.

In more seriously ill patients, begin infusion of dopamine hydrochloride solution at dosage of 5 micrograms/kg/min and increase gradually using 5 to 10 micrograms/kg/min increment up to 20 to 50 micrograms/kg/min as needed. If dosage in excess of 50 micrograms/kg/min are required, it is suggested that urine output should be checked frequently. In patients who do not respond to this doses, additional increments of dopamine may be given in an effort to achieve adequent blood pressure, urine flow and perfusion.

For patients with severe, refractory, chronic congestive heart failure doses should be started on 0.5 to 2 micrograms/kg/min, and the dose increased by 1 to 3 micrograms/kg/min as urinary output increases.

ECG, blood pressure and urine output should be monitored. Cardiac output and pulmonary wedge pressure should be monitored if possible.

Children less than 12 years old: The safety and efficacy of dopamine in children under 12 years has not been established.

Geriatric patients: No variation in dosage is suggested for geriatric patients. However, close monitoring is required for blood pressure, urine flow, and peripheral tissue perfusion.

The dosage of Dopamine-Rotex IV Injection 200 mg/5 ml is highly individualized based on the patient's condition and response to treatment. Typical dosing ranges are:

For shock: 2-20 mcg/kg/min, adjusted according to the patient's blood pressure and heart rate.
For renal perfusion: Lower doses (2-5 mcg/kg/min) may be used to enhance renal blood flow.

Dosage adjustments are often necessary based on clinical response and side effects.

Administration

Dopamine-Rotex IV Injection 200 mg/5 ml is administered via continuous intravenous infusion. The infusion rate is adjusted according to the patient's response and the desired therapeutic effect. Monitoring of vital signs and cardiac function is essential during administration.

Side Effects

Potential side effects of Dopamine-Rotex IV Injection 200 mg/5 ml include:

Tachycardia (increased heart rate).
Hypertension (high blood pressure).
Arrhythmias (irregular heartbeats).
Nausea and vomiting.
Headache.

Toxicity

Signs of toxicity may include severe hypertension, tachycardia, or arrhythmias. In cases of overdose or severe adverse reactions, the infusion should be discontinued immediately and supportive measures should be taken. Monitoring and dose adjustments are crucial to avoid toxicity.

Precautions

Precautions when using Dopamine-Rotex IV Injection 200 mg/5 ml include:

Careful monitoring of blood pressure and heart rate.
Adjustment of dose based on response to avoid excessive vasoconstriction or tachycardia.
Consideration of underlying cardiac conditions or renal impairment when adjusting dosage.

Interaction

Dopamine-Rotex IV Injection 200 mg/5 ml may interact with other medications, such as:

Beta-blockers, which may counteract the effects of dopamine on heart rate and blood pressure.
MAO inhibitors, which can enhance the effects of dopamine and increase the risk of hypertensive crises.

Disease Interaction

Dopamine-Rotex IV Injection 200 mg/5 ml should be used with caution in patients with:

Pre-existing cardiovascular diseases or arrhythmias.
Renal impairment, as it may alter the effects on kidney function.

Drug Interaction

Drug interactions with Dopamine-Rotex IV Injection 200 mg/5 ml may include:

Increased risk of arrhythmias when used with other drugs that affect cardiac rhythm.
Potential for altered blood pressure control when used with antihypertensive medications.

Food Interactions

There are no significant food interactions with Dopamine-Rotex IV Injection 200 mg/5 ml. However, it is important to follow any specific instructions related to diet or fluid intake provided by the healthcare provider.

Pregnancy Use

The use of Dopamine-Rotex IV Injection 200 mg/5 ml during pregnancy should be considered only if the potential benefits outweigh the risks. It is classified as a Category C drug, meaning that there is insufficient data on its safety during pregnancy. Consult a healthcare provider before use.

Lactation Use

It is not known whether Dopamine-Rotex IV Injection 200 mg/5 ml is excreted in breast milk. Caution should be exercised when administering this medication to lactating women. Consult a healthcare provider to assess risks and benefits.

Acute Overdose

Acute overdose of Dopamine-Rotex IV Injection 200 mg/5 ml can lead to severe hypertension, tachycardia, or arrhythmias. Immediate discontinuation of the infusion and supportive care are necessary. Treatment may involve medications to manage blood pressure and heart rate.

Contraindication

Dopamine-Rotex IV Injection 200 mg/5 ml is contraindicated in patients with:

Hypovolemia (low blood volume) unless adequately corrected.
Known hypersensitivity to dopamine or any component of the formulation.

Use Direction

Follow the dosage and administration instructions provided by a healthcare provider. Continuous monitoring of vital signs and adjustment of the infusion rate based on patient response are crucial for effective and safe treatment.

Storage Conditions

Dopamine-Rotex IV Injection 200 mg/5 ml should be stored at room temperature, away from light and moisture. Ensure that the medication is kept out of reach of children and disposed of properly if no longer needed.

Volume of Distribution

The volume of distribution for Dopamine-Rotex IV Injection 200 mg/5 ml is not well defined but is generally considered to be limited to the extracellular fluid due to its rapid metabolism and systemic effects.

Half Life

The half-life of Dopamine-Rotex IV Injection 200 mg/5 ml is relatively short, approximately 1-2 minutes, due to rapid metabolism and elimination. Continuous infusion is required to maintain therapeutic levels and effects.

Clearance

Dopamine is cleared from the body primarily through metabolic processes in the liver and kidneys. The clearance rate is influenced by factors such as dosage, patient condition, and concurrent medications.

See in details version Dopamine-Rotex IV Injection 200 mg/5 ml also Dopamine-Rotex IV Injection 200 mg/5 ml in bangla